NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunothe...
/PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer,...
prnewswire.com